COVID-19 and the Use Of Angiotensin-Converting Enzyme Inhibitors and Receptor Blockers


Concerns exist that angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARBs) increase susceptibility to coronavirus SARS CoV-2 (the virus that causes the disease COVID-19) and the likelihood of severe COVID-19 illness.

Abstract